The Patent Finder

Aslan Pharmaceuticals Pte Ltd.

Also on record
Records under this name other than the patents Aslan Pharmaceuticals Pte Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Aslan Pharmaceuticals Pte Ltd.

PatentTitleStatus Expires Confidence
US 11,382,903Cancer Therapy
Lapsed on the fee record
Ended Jul 12, 2026 · High confidence
Lapsed on the fee recordEnded Jul 12, 2026High confidence
US 11,311,548Cancer Therapy
Lapsed on the fee record
Ended Apr 26, 2026 · High confidence
Lapsed on the fee recordEnded Apr 26, 2026High confidence
US 10,849,899Combination Therapy Comprising Varlitinib and an Anticancer Agent
Lapsed on the fee record
Ended Dec 1, 2024 · High confidence
Lapsed on the fee recordEnded Dec 1, 2024High confidence
15/757,166Treatment of Biliary Duct Cancer
Abandoned
Abandoned Oct 13, 2019
AbandonedAbandoned Oct 13, 2019
16/094,199Method of Treating Liver Cancer
Abandoned
Abandoned Jul 22, 2020
AbandonedAbandoned Jul 22, 2020
16/134,736Treatment of Biliary Duct Cancer
Abandoned
Abandoned Feb 14, 2020
AbandonedAbandoned Feb 14, 2020
16/312,816Maintenance Therapy for the Treatment of Cancer
Abandoned
Abandoned Sep 12, 2020
AbandonedAbandoned Sep 12, 2020
16/625,902Method of Treatment for Cutaneous T Cell Lymphoma Using IL-13R Antibody
Abandoned
Abandoned Feb 11, 2022
AbandonedAbandoned Feb 11, 2022
17/272,243Treatment Employing ANTI-IL-13R Antibody or Binding Fragment Thereof
now held by Vellera Therapeutics, Inc.
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
17/283,724Malonate Salt of Varlitinib
Abandoned
Abandoned Aug 5, 2024
AbandonedAbandoned Aug 5, 2024
10 of 22 records shown.
Pro members see all 22.
Pro members: see all 22 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited